Joe Regan
Direttore/Membro del Consiglio presso Aegera Therapeutics, Inc.
Profilo
Joe Regan is currently a Director at LMS Medical Systems Ltd, Natrix Separations, Inc., Aegera Therapeutics, Inc., and Managing Partner at BDC Venture Capital.
He previously worked as a Director at Targeted Growth, Inc., Molecular Templates, Inc., gShift Labs, Inc., Kytogenics Pharmaceuticals Ltd., Dynacon, Inc., Ambit Biosciences Corp., Cytochroma, Inc., Receptor Therapeutics, Inc., Viron Therapeutics, Inc., ViOptix, Inc., and Vice President-Investments at GrowthWorks Capital Ltd.
Mr. Regan holds an MBA from McMaster University and an undergraduate degree from the University of Guelph.
Posizioni attive di Joe Regan
| Società | Posizione | Inizio |
|---|---|---|
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Direttore/Membro del Consiglio | - |
LMS Medical Systems Ltd
 LMS Medical Systems Ltd Packaged SoftwareTechnology Services Part of Halma Plc, LMS Medical Systems Ltd develops monitoring software for medical uses. The company is based in Montréal, Canada. The Canadian company was founded by James W. G. Turner. LMS Medical Systems was acquired by Maclos Capital, Inc. on April 01, 2004. | Direttore/Membro del Consiglio | - |
NATRIX Separations, Inc.
 NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Direttore/Membro del Consiglio | - |
BDC Venture Capital
 BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investitore di Private Equity | 01/06/2019 |
Precedenti posizioni note di Joe Regan
| Società | Posizione | Fine |
|---|---|---|
| AMBIT BIOSCIENCES CORP | Direttore/Membro del Consiglio | 19/08/2013 |
ViOptix, Inc.
 ViOptix, Inc. Medical SpecialtiesHealth Technology ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA. | Direttore/Membro del Consiglio | - |
Kytogenics Pharmaceuticals Ltd.
 Kytogenics Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Kytogenics Pharmaceuticals, Inc. develops medical devices and drug delivery systems. It develops and markets a series of clinically significant therapies and products based on its N,O- carboxymethylchitosan chitosan derived technology and its sulfated derivative s-NOCC. The firm has also in Phase III Pivotal Clinical Trial, a polymeric gel product for surgical adhesion prevention. The company was founded by Marina P. Zazanis and Ashley J. Stevens in 1993 and is headquartered in Dartmouth, Canada. | Direttore/Membro del Consiglio | - |
gShift Labs, Inc.
 gShift Labs, Inc. Packaged SoftwareTechnology Services gShift Labs, Inc. engages in the provision of web presence analytics software. It offers brand development, competitive assessment, digital recruitment, content, influencer, integrated social media, and paid marketing, SEO marketing, web consulting and site audit services. The company was founded in 2009 by Krista LaRiviere and Chris Adams and is headquartered in Barrie, Canada. | Direttore/Membro del Consiglio | - |
Receptor Therapeutics, Inc.
 Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | - |
Formazione di Joe Regan
| University of Guelph | Undergraduate Degree |
| McMaster University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
LMS Medical Systems Ltd
LMS Medical Systems Ltd Packaged SoftwareTechnology Services Part of Halma Plc, LMS Medical Systems Ltd develops monitoring software for medical uses. The company is based in Montréal, Canada. The Canadian company was founded by James W. G. Turner. LMS Medical Systems was acquired by Maclos Capital, Inc. on April 01, 2004. | Technology Services |
ViOptix, Inc.
ViOptix, Inc. Medical SpecialtiesHealth Technology ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA. | Health Technology |
Targeted Growth, Inc.
 Targeted Growth, Inc. Chemicals: AgriculturalProcess Industries Targeted Growth, Inc. provides biotechnological services for agricultural and energy industries. Its products include algae, canola, corn, soybean and wheat. The company was founded by Robert W. Day, James Michael Roberts, Thomas M. Todaro and Luca Comai in 1998 and is headquartered in Seattle, WA. | Process Industries |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
GrowthWorks Capital Ltd.
 GrowthWorks Capital Ltd. Investment ManagersFinance GrowthWorks Capital Ltd. (GrowthWorks) is a venture capital firm founded in 1992 by David Levi. The firm is headquartered in Vancouver, Columbia with additionaal offices in Saskatchewan, Manitoba, New Brunswick, Newfoundland, Nova Scotia, and Ontario. | Finance |
BDC Venture Capital
BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Finance |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Health Technology |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Health Technology |
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Health Technology |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
Receptor Therapeutics, Inc.
Receptor Therapeutics, Inc. BiotechnologyHealth Technology Receptor Therapeutics, Inc. was a bio-pharmaceutical company focused on in-licensing and developing anti-cancer therapies. The company was founded in 2007 and was headquartered in Toronto, Canada. | Health Technology |
Kytogenics Pharmaceuticals Ltd.
Kytogenics Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Kytogenics Pharmaceuticals, Inc. develops medical devices and drug delivery systems. It develops and markets a series of clinically significant therapies and products based on its N,O- carboxymethylchitosan chitosan derived technology and its sulfated derivative s-NOCC. The firm has also in Phase III Pivotal Clinical Trial, a polymeric gel product for surgical adhesion prevention. The company was founded by Marina P. Zazanis and Ashley J. Stevens in 1993 and is headquartered in Dartmouth, Canada. | Health Technology |
Dynacon, Inc.
 Dynacon, Inc. Electronic Equipment/InstrumentsElectronic Technology Dynacon, Inc. designed and integrated pre-analytical microbiology automation solutions. The company was founded in 1975 and was headquartered in Mississauga, Canada. | Electronic Technology |
gShift Labs, Inc.
gShift Labs, Inc. Packaged SoftwareTechnology Services gShift Labs, Inc. engages in the provision of web presence analytics software. It offers brand development, competitive assessment, digital recruitment, content, influencer, integrated social media, and paid marketing, SEO marketing, web consulting and site audit services. The company was founded in 2009 by Krista LaRiviere and Chris Adams and is headquartered in Barrie, Canada. | Technology Services |
- Borsa valori
- Insiders
- Joe Regan